Society for Human Resource Management (SHRM): Maximizing the Potential of Biosimilars to Support Your Workforce

The Society for Human Resource Management (SHRM) is hosting a webinar on Maximizing the Potential of Biosimilars to Support your Workforce on Wednesday, June 26^th, starting at 2:00.

Biosimilars are disrupting the market by helping drive down costs while providing clinically safe coverage options and effective continuity of care for your workforce. In the U.S., the biosimilars market is projected to grow from less than $10 billion in 2022 to more than $100 billion by 2029. A biosimilar is an FDA-approved medicine that has been developed to be highly similar to the original biologic reference product and has no clinically meaningful differences compared to it. In this webcast, we’ll cover an overview of biosimilars, innovative strategies for ensuring biosimilar adoption, and insights into the vibrant and competitive biosimilar pipeline.

Click here to learn more and register.